FGF23 in type 2 diabetic patients: relationship with bone metabolism and vascular disease.
Corresponding author: Manuel Muñoz-Torres, mmt@mamuto.es.
Rebeca
R
Reyes-Garcia
Antonia
A
Garcia-Martín
Beatriz
B
García-Fontana
Sonia
S
Morales-Santana
Pedro
P
Rozas-Moreno
Manuel
M
Muñoz-Torres
D015519:Bone Density / Q000502:physiology; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D003925:Diabetic Angiopathies / Q000097:blood / Q000150:complications*; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000378:metabolism*; D006801:Humans; D010024:Osteoporosis / Q000097:blood / Q000209:etiology*; D058866:Osteoporotic Fractures / Q000097:blood / Q000209:etiology*
C000717427:FGF23 protein, human; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23